MyPsoriasisTeam

Taltz (ixekizumab) is a biologic drug used to treat psoriatic arthritis (PsA) and moderate to severe plaque psoriasis. It works by binding to a protein called interleukin-17A, which promotes inflammation. Taltz is administered by subcutaneous injection every four weeks after initial loading doses. Common side effects Show Full Answer

Taltz (ixekizumab) is a biologic drug used to treat psoriatic arthritis (PsA) and moderate to severe plaque psoriasis. It works by binding to a protein called interleukin-17A, which promotes inflammation. Taltz is administered by subcutaneous injection every four weeks after initial loading doses. Common side effects include injection site reactions, upper respiratory tract infections, nausea, and ringworm. Rare but serious side effects include serious infections like tuberculosis, hypersensitivity reactions, and inflammatory bowel disease.

For more details, you can visit the [Taltz page on MyPsoriasisTeam](https://www.mypsoriasisteam.com/treatments/taltz).

 This AI-generated response comes from MyPsoriasisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Taltz (Ixekizumab) for Psoriasis | MyPsoriasisTeam

Injections for Psoriasis Treatment | MyPsoriasisTeam